New combo shrinks liver tumors in hard-to-treat colorectal cancer
Disease control
Completed
This study tested a treatment for people with colorectal cancer that spread to the liver and had not responded to at least two prior therapies. The treatment combined a strong chemotherapy cocktail delivered directly to the liver (FOLFOXIRI via hepatic arterial infusion) with an …
Phase: PHASE2 • Sponsor: Meng Qiu • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC